Breaking News Instant updates and real-time market news.

NKTR

Nektar

$22.24

0.07 (0.32%)

07:25
07/24/17
07/24
07:25
07/24/17
07:25

Nektar trading halted, news pending

NKTR Nektar
$22.24

0.07 (0.32%)

03/21/17
JPMS
03/21/17
NO CHANGE
Target $24
JPMS
Overweight
Nektar price target raised to $24 from $18 at JPMorgan
JPMorgan analyst Jessica Fye raised her price target for Nektar Therapeutics to $24 citing the positive phase III results for NKTR-181 in pain. The analyst sees a "strong probability" that Nektar partners the drug through the rest of phase III development and to commercialization. She keeps an Overweight rating on the shares.
05/30/17
ROTH
05/30/17
NO CHANGE
Target $31
ROTH
Buy
Gottlieb remarks suggest more leeway for Nektar drug approval, says Roth Capital
Roth Capital analyst Michael Higgins noted that the first FDA Voice Blog issued by new commissioner Scott Gottlieb was dedicated to the ongoing opioid abuse crisis and he believes Gottlieb is directing the FDA to be more aggressive and take every opportunity to try to reduce prescription opioid and heroin abuse. Prior to Gottlieb's blog, Higgins had expected Nektar would need to run another Phase 3 trial before the NKTR-181 NDA could be filed; after it he now believes NKTR-181's NDA will not require another such trial. The analyst has a Buy rating and $31 price target on Nektar shares.
06/05/17
ROTH
06/05/17
NO CHANGE
Target $31
ROTH
Buy
Nektar NKTR-214 efficacy, safety signals encouraging, says Roth Capital
Roth Capital analyst Michael Higgins said Nektar's update at ASCO on NKTR-214, its Phase 2-ready IO candidate, included encouraging efficacy and safety and tolerability signals. He keeps a Buy rating and $31 price target on Nektar shares.
07/18/17
JPMS
07/18/17
NO CHANGE
JPMS
Overweight
Nektar data support differentiated abuse potential, says JPMorgan
JPMorgan analyst Jessica Fye believes this morning's data from Nektar Therapeutics reinforce a differentiated abuse potential for NKTR-181 in an environment where the opioid epidemic is receiving increased regulatory focus. She also sees the data as key for securing a potential partner to help commercialize the pain drug. The analyst thinks Nektar's pipeline over the next 12-18 months has a number of catalysts. She reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

P

Pandora

$5.03

0.13 (2.65%)

, GPS

Gap

$33.60

0.11 (0.33%)

09:03
12/12/17
12/12
09:03
12/12/17
09:03
Hot Stocks
Pandora names Aimee Lapic as Chief Marketing Officer, effective December 13 »

Pandora (P) announced…

P

Pandora

$5.03

0.13 (2.65%)

GPS

Gap

$33.60

0.11 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ALLY

Ally Financial

$28.77

0.12 (0.42%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Hot Stocks
Ally Financial appoints Jenn LaClair as CFO designate »

Ally Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

ACER

Acer Therapeutics

$14.15

-0.42 (-2.88%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Syndicate
Acer Therapeutics 917K share Spot Secondary priced at $12.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ACM

Aecom

$38.51

-0.06 (-0.16%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Hot Stocks
Aecom raises five-year adjusted EPS growth forecast to 12%-15% »

AECOM will hold its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

OAS

Oasis Petroleum

09:00
12/12/17
12/12
09:00
12/12/17
09:00
Syndicate
Oasis Petroleum 32M share Spot Secondary priced at $9.55 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

PRSC

Providence Service

$58.26

0.08 (0.14%)

09:00
12/12/17
12/12
09:00
12/12/17
09:00
Syndicate
Providence Service 320K share Block Trade priced at $56.75 »

Jefferies acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DXTR

Dextera Surgical

$0.14

-0.003 (-2.14%)

09:00
12/12/17
12/12
09:00
12/12/17
09:00
Hot Stocks
Breaking Hot Stocks news story on Dextera Surgical »

Dextera Surgical trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$24.85

-1.11 (-4.28%)

08:59
12/12/17
12/12
08:59
12/12/17
08:59
Recommendations
Glaukos analyst commentary  »

Reimbursement remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLYC

GlycoMimetics

$14.32

-0.65 (-4.34%)

08:57
12/12/17
12/12
08:57
12/12/17
08:57
Recommendations
GlycoMimetics analyst commentary  »

GlycoMimetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

08:56
12/12/17
12/12
08:56
12/12/17
08:56
General news
Redbook Store Sales data reported »

Week of 12/9 Redbook…

BAC

Bank of America

$28.94

-0.11 (-0.38%)

, T

AT&T

$36.90

0.17 (0.46%)

08:55
12/12/17
12/12
08:55
12/12/17
08:55
Options
Notable open interest changes for December 12th »

Monday's total…

BAC

Bank of America

$28.94

-0.11 (-0.38%)

T

AT&T

$36.90

0.17 (0.46%)

AAPL

Apple

$172.67

3.3 (1.95%)

MU

Micron

$43.01

-0.2 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 09

    Jan

08:55
12/12/17
12/12
08:55
12/12/17
08:55
General news
Treasury Action: yields extended their rise »

Treasury Action: yields…

HI

Hillenbrand

$45.10

-0.45 (-0.99%)

08:55
12/12/17
12/12
08:55
12/12/17
08:55
Conference/Events
Hillenbrand to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ARGX

Argenx

$54.47

24.02 (78.88%)

08:54
12/12/17
12/12
08:54
12/12/17
08:54
Technical Analysis
Technical View: Argenx falls after filing to sell $150M in ADSs »

In premarket trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$32.27

-0.82 (-2.48%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Recommendations
Urban Outfitters analyst commentary  »

Urban Outfitters price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

H

Hyatt

$71.90

-0.39 (-0.54%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Syndicate
Hyatt 2.7M share Block Trade priced at $71.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Dec

AGN

Allergan

$172.76

4.96 (2.96%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Hot Stocks
Allergan receives FDA clearance for CoolSculpting treatment »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

GRMN

Garmin

$61.96

-0.31 (-0.50%)

08:52
12/12/17
12/12
08:52
12/12/17
08:52
Recommendations
Garmin analyst commentary  »

Garmin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
12/12/17
12/12
08:50
12/12/17
08:50
General news
FX Action: The dollar »

FX Action: The dollar…

ESL

Esterline

$70.80

0.95 (1.36%)

08:49
12/12/17
12/12
08:49
12/12/17
08:49
Recommendations
Esterline analyst commentary  »

Esterline price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$283.16

-2.74 (-0.96%)

08:48
12/12/17
12/12
08:48
12/12/17
08:48
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYCEY

Rolls-Royce

$11.08

-0.145 (-1.29%)

08:46
12/12/17
12/12
08:46
12/12/17
08:46
Hot Stocks
Rolls-Royce launches R2 Data Labs to accelerate data innovation »

Rolls-Royce has launched…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAOI

Applied Optoelectronics

$40.52

1.83 (4.73%)

, ROKU

Roku

$47.98

3.19 (7.12%)

08:45
12/12/17
12/12
08:45
12/12/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

AAOI

Applied Optoelectronics

$40.52

1.83 (4.73%)

ROKU

Roku

$47.98

3.19 (7.12%)

RSX

Market Vectors Russia ETF

$22.01

0.44 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIBB

Hibbett Sports

$20.20

0.05 (0.25%)

08:43
12/12/17
12/12
08:43
12/12/17
08:43
Technical Analysis
Technical View: Hibbett Sports moves higher on light volume »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$112.37

-0.23 (-0.20%)

08:42
12/12/17
12/12
08:42
12/12/17
08:42
Periodicals
Visa innovation chief had history of employee affairs before firing, Recode says »

Former Visa executive Jim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.